Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

To be and to have a critical friend in medical teaching.

Dahlgren LO, Eriksson BE, Gyllenhammar H, Korkeila M, Sääf-Rothoff A, Wernerson A, Seeberger A.

Med Educ. 2006 Jan;40(1):72-8.

PMID:
16441326
2.

[Chronic granulomatous disease--not only the lack of oxygen radicals].

Palmblad J, Gyllenhammar H, Bratt J, Ahlin A.

Lakartidningen. 2005 Apr 4-10;102(14):1036-8, 1041. Review. Swedish.

PMID:
15892472
3.

Adenosine treatment attenuates cytokine interleukin-6 responses to endotoxin challenge in healthy volunteers.

Soop A, Johansson C, Hjemdahl P, Kristiansson M, Gyllenhammar H, Li N, Sollevi A.

Shock. 2003 Jun;19(6):503-7.

PMID:
12785003
4.

Nitric oxide and endothelin concentrations during intravenous infusion of urological irrigating fluid.

Sandfeldt L, Gyllenhammar H, Hahn RG.

Scand J Urol Nephrol. 2003;37(1):55-9.

PMID:
12745746
5.

Modulation of plasma levels of soluble adhesion molecules and nitric oxide in healthy volunteers by exposure to swine dust.

Kölbeck KG, Sardh E, Gyllenhammar H, Palmberg L, Larsson K K, Palmblad J.

Inflammation. 2002 Dec;26(6):291-6.

PMID:
12546138
6.

Airway reactivity and exhaled NO following swine dust exposure in healthy volunteers.

Kölbeck KG, Ehnhage A, Juto JE, Forsberg S, Gyllenhammar H, Palmberg L, Larsson K.

Respir Med. 2000 Nov;94(11):1065-72.

7.

Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans.

Elizalde M, Rydén M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, Ramel S, Olund A, Arner P, Andersson K.

J Lipid Res. 2000 Aug;41(8):1244-51.

8.

No effect of carvedilol on nitric oxide generation in phagocytes but modulation of production of superoxide ions.

Asbrink S, Zickert A, Bratt J, Gyllenhammar H, Palmblad J.

Biochem Pharmacol. 2000 Apr 15;59(8):1007-13.

PMID:
10692566
9.

Electrochemical detection of nitric oxide production in human polymorphonuclear neutrophil leukocytes.

Lärfars G, Lantoine F, Devynck MA, Gyllenhammar H.

Scand J Clin Lab Invest. 1999 Aug;59(5):361-8.

PMID:
10533848
10.
11.
12.

Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes.

Lärfars G, Lantoine F, Devynck MA, Palmblad J, Gyllenhammar H.

Blood. 1999 Feb 15;93(4):1399-405.

13.
16.

Neutrophil membrane potential changes and homotypic aggregation kinetics are pH-dependent: studies of chronic granulomatous disease.

Ahlin A, Gyllenhammar H, Ringertz B, Palmblad J.

J Lab Clin Med. 1995 Mar;125(3):392-401.

PMID:
7897306
17.

Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden.

Osterborg A, Björkholm M, Björeman M, Brenning G, Carlson K, Celsing F, Gahrton G, Grimfors G, Gyllenhammar H, Hast R, et al.

Blood. 1993 Mar 15;81(6):1428-34.

18.

Treatment of multiple myeloma with interferon alpha: the Scandinavian experience.

Mellstedt H, Osterborg A, Björkholm M, Björeman M, Brenning G, Gahrton G, Grimfors G, Gyllenhammar H, Hast R, Juliusson G, et al.

Br J Haematol. 1991 Oct;79 Suppl 1:21-5.

PMID:
1931703
19.

Effects of an essential fatty acid-supplemented diet on leukotriene B4-induced rat neutrophil functions.

Gyllenhammar H, Palmblad J, Ringertz B.

Scand J Clin Lab Invest. 1991 Oct;51(6):525-32.

PMID:
1662827
20.

The effect of 20-trifluoromethyl leukotriene B4 on neutrophil functional responses.

Nilsson E, Gyllenhammar H, Lerner R, Palmblad J, Ringertz B.

Scand J Immunol. 1991 Apr;33(4):357-63.

PMID:
1850167
21.

[Occurrence of chronic granulomatous disease must be surveyed--new treatment exists].

Palmblad J, Gyllenhammar H, Ringertz B, Elinder G, Lidefelt KJ, Ahlin A, Smith E, Hammarström L.

Lakartidningen. 1991 Feb 13;88(7):508-9, 511. Swedish. No abstract available.

PMID:
1900341
22.

Dietary linoleate supplementation modulates formyl-peptide receptor expression and functional responses of rat neutrophils.

Gyllenhammar H, Hafström I, Borgeat P, Ringertz B, Becker W, Svensson J, Palmblad J.

J Lab Clin Med. 1990 Apr;115(4):487-96.

PMID:
2157784
23.

Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central Sweden.

Osterborg A, Ahre A, Björkholm M, Björeman M, Brenning G, Gahrton G, Grimfors G, Gyllenhammar H, Hast R, Johansson B, et al.

Acta Oncol. 1990;29(6):727-31.

PMID:
2223143
24.

Substance P activates and modulates neutrophil oxidative metabolism and aggregation.

Hafström I, Gyllenhammar H, Palmblad J, Ringertz B.

J Rheumatol. 1989 Aug;16(8):1033-7.

PMID:
2479743
25.

Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS.

Osterborg A, Ahre A, Björkholm M, Björeman M, Brenning G, Gahrton G, Gyllenhammar H, Johansson B, Juliusson G, Järnmark M, et al.

Eur J Haematol. 1989 Jul;43(1):54-62.

PMID:
2670605
30.

Induction treatment with alpha-interferon in multiple myeloma: an interim report from MGCS.

Mellstedt H, Osterborg A, Björkholm M, Björeman M, Brenning G, Gahrton G, Grimfors G, Gyllenhammar H, Hast R, Johansson B, et al.

Eur J Haematol Suppl. 1989;51:124-8.

PMID:
2697585
31.

Leukotriene B4 triggers highly characteristic and specific functional responses in neutrophils: studies of stimulus specific mechanisms.

Palmblad J, Gyllenhammar H, Ringertz B, Nilsson E, Cottell B.

Biochim Biophys Acta. 1988 Aug 19;971(1):92-102.

PMID:
2457394
32.

High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS).

Ahre A, Björkholm M, Osterborg A, Brenning G, Gahrton G, Gyllenhammar H, Holm G, Johansson B, Juliusson G, Järnmark M, et al.

Eur J Haematol. 1988 Aug;41(2):123-30.

PMID:
3410007
33.

Recombinant human leukocyte interferon modulates neutrophil function in vitro.

Gyllenhammar H, Hafström I, Ringertz B, Uden AM, Palmblad J.

J Interferon Res. 1988 Aug;8(4):441-9.

PMID:
2844926
34.

Effect of dietary lipids on immunity and inflammation. Review article.

Palmblad J, Gyllenhammar H.

APMIS. 1988 Jul;96(7):571-83. Review. No abstract available.

PMID:
2841953
35.

Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis.

Hafström I, Ringertz B, Gyllenhammar H, Palmblad J, Harms-Ringdahl M.

Arthritis Rheum. 1988 May;31(5):585-92.

PMID:
2837251
36.

Rat neutrophil function, and leukotriene generation in essential fatty acid deficiency.

Gyllenhammar H, Palmblad J, Ringertz B, Hafström I, Borgeat P.

Lipids. 1988 Feb;23(2):89-95.

PMID:
2835569
37.

Effects of lipoxins A and B on functional responses of human granulocytes.

Palmblad J, Gyllenhammar H, Ringertz B.

Adv Exp Med Biol. 1988;229:137-45.

PMID:
2844068
38.

The effects of lipoxin A and lipoxin B on functional responses of human granulocytes.

Palmblad J, Gyllenhammar H, Ringertz B, Serhan CN, Samuelsson B, Nicolaou KC.

Biochem Biophys Res Commun. 1987 May 29;145(1):168-75.

PMID:
3593338
39.

Lucigenin chemiluminescence in the assessment of neutrophil superoxide production.

Gyllenhammar H.

J Immunol Methods. 1987 Mar 12;97(2):209-13.

PMID:
3029229
40.

High dietary linoleic acid content modulates neutrophil function in rats.

Ringertz B, Gyllenhammar H, Palmblad J, Friberg I, Cottell B, Becker W, Borgeat P.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:858-61. No abstract available.

PMID:
2960199
41.

Dietary essential fatty acid deficiency in rats is accompanied by impairments in neutrophil function and leukotriene B4 generation.

Gyllenhammar H, Ringertz B, Palmblad J, Cottell B, Friberg I, Becker W, Borgeat P.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:846-9. No abstract available.

PMID:
2823572
42.
43.

Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden.

Ahre A, Björkholm M, Mellstedt H, Brenning G, Engstedt L, Gahrton G, Gyllenhammar H, Holm G, Johansson B, Järnmark M, et al.

Cancer Treat Rep. 1984 Nov;68(11):1331-8.

PMID:
6388832
44.

Acute leukaemia in a defined geographic area--incidence, clinical history and prognosis.

Ost A, Lindström P, Christensson B, Gyllenhammar H, Engsted L.

Scand J Haematol. 1984 Aug;33(2):160-70.

PMID:
6591386
45.

Effects of leukotrienes and f-Met-Leu-Phe on oxidative metabolism of neutrophils and eosinophils.

Palmblad J, Gyllenhammar H, Lindgren JA, Malmsten CL.

J Immunol. 1984 Jun;132(6):3041-5.

PMID:
6327816
46.

[Why is myelomatosis often diagnosed so late?].

Gyllenhammar H, Engstedt L.

Lakartidningen. 1983 Sep 14;80(37):3317-20. Swedish. No abstract available.

PMID:
6633067

Supplemental Content

Loading ...
Support Center